Legal Representation
Attorney
Jonathan A. Hyman
USPTO Deadlines
Next Deadline
147 days remaining
NOA E-Mailed - SOU Required
Due Date
December 24, 2025
Extension Available
Until June 24, 2026
Application History
24 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 24, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 29, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 29, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 23, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 1, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 31, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Mar 31, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Mar 31, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Mar 31, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 17, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 17, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 17, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 16, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 16, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 16, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 17, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 17, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 17, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 28, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 12, 2024 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Jan 12, 2024 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Aug 28, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 21, 2023 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Jul 31, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Medicinal infusions for treating viral, inflammatory, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary dysfunction, oncological, hematological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders, blood disorders, cancers, and fibrotic and neurodegenerative diseases; Drugs for medical purposes, namely, pharmaceutical preparations for treating viral, inflammatory, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary dysfunction, oncological, hematological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders, blood disorders, cancers, and fibrotic and neurodegenerative diseases; Therapeutic drugs and agents, namely, pharmaceutical preparations for treating viral, inflammatory, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary dysfunction, oncological, hematological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders, blood disorders, cancers, and fibrotic and neurodegenerative diseases; Pharmaceutical preparations for treating viral, inflammatory, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary dysfunction, oncological, hematological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders, blood disorders, cancers, and fibrotic and neurodegenerative diseases; Drug delivery agents in the form of infusion bags filled with platelets, infusion bags filled with platelets in suspension ready for infusion, infusion bags filled with lyophilized platelets, infusion bags filled with lyophilized platelets to be resuspended before infusion, infusion bags filled with cryopreserved platelets, infusion bags filled with cryopreserved platelets to be thawed prior to infusion that facilitate the delivery of proteins, peptides, long and short RNA, siRNA, miRNA, and saRNA; Drug delivery agents in the form of infusion bags filled with platelets, infusion bags filled with platelets in suspension ready for infusion, infusion bags filled with lyophilized platelets, infusion bags filled with lyophilized platelets to be resuspended before infusion, infusion bags filled with cryopreserved platelets, infusion bags filled with cryopreserved platelets to be thawed prior to infusion consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Medicines for treating viral, inflammatory, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary dysfunction, oncological, hematological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders, blood disorders, cancers, and fibrotic and neurodegenerative diseases; Pre-filled syringes and infusion bags for medical purposes featuring pharmaceutical preparations for treating viral, inflammatory, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary dysfunction, oncological, hematological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders, blood disorders, cancers, and fibrotic and neurodegenerative diseases; Drug delivery agents infused in a patient's blood consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
Class 042
Testing and analysis of blood plasma, red blood cells, white blood cells, blood platelets for scientific research purposes
Class 044
Platelet-rich plasma therapy; blood banks
Classification
International Classes
005
042
044